Picture of Zydus Lifesciences logo

ZYDUSLIFE — Zydus Lifesciences News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

India's Zydus Lifesciences falls after US FDA inspection ends with five observations

BUZZ-India's Zydus Lifesciences falls after US FDA inspection ends with five observations

** Shares of pharmaceuticals company Zydus LifesciencesZYDU.NS fell as much as 2.03% to 1,109.50 rupees

** US FDA closed inspection at co's Ahmedabad manufacturing plant with five observations, co said

** ZYDU closely working with FDA to address observations--statement

** Stock's F12M PE ratio of 24.98 vs industry median of 25.98--LSEG-compiled data

** 29 analysts, on average, rate the stock "hold", median TP at 1,205 rupees--LSEG-compiled data

** YTD, shares up 21.65%



(Reporting by Saikeerthi in Bengaluru)

((Saikeerthi@thomsonreuters.com;))

Recent news on Zydus Lifesciences

See all news